MX9803841A - Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi. - Google Patents

Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.

Info

Publication number
MX9803841A
MX9803841A MX9803841A MX9803841A MX9803841A MX 9803841 A MX9803841 A MX 9803841A MX 9803841 A MX9803841 A MX 9803841A MX 9803841 A MX9803841 A MX 9803841A MX 9803841 A MX9803841 A MX 9803841A
Authority
MX
Mexico
Prior art keywords
compounds
cruzi
methods
cruzi infection
prevention
Prior art date
Application number
MX9803841A
Other languages
English (en)
Inventor
Steven G Reed
Yasir A Skeiky
Michael J Lodes
Raymond L Houghton
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24224889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9803841(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of MX9803841A publication Critical patent/MX9803841A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se proveen compuestos y métodos para diagnosticar infeccion per T. cruzi. Los compuestos descritos son polipéptidos o anticuerpos para lo mismo, que contienen uno o más epitopes de antígenos de T. cruzi. Los compuestos son utiles en una variedad de inmunoanálisis para detectar infeccion por T. cruzi. Los compuestos de polipéptidos son utiles además en vacunas y composiciones farmacéuticas para inducir inmunidad protectora contra la enfermedad de Chagas en individuos expuestos a T. cruzi.
MX9803841A 1995-11-14 1998-05-14 Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi. MX9803841A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/557,309 US5916572A (en) 1995-11-14 1995-11-14 Compounds and methods for the detection and prevention of T. cruzi infection

Publications (1)

Publication Number Publication Date
MX9803841A true MX9803841A (es) 1998-09-30

Family

ID=24224889

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803841A MX9803841A (es) 1995-11-14 1998-05-14 Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.

Country Status (14)

Country Link
US (1) US5916572A (es)
EP (1) EP0874992B1 (es)
JP (1) JP2000503111A (es)
AR (1) AR004567A1 (es)
AT (1) ATE213544T1 (es)
AU (1) AU722152B2 (es)
BR (1) BRPI9611455B8 (es)
CA (1) CA2237299A1 (es)
DE (1) DE69619405T2 (es)
DK (1) DK0874992T3 (es)
ES (1) ES2168520T3 (es)
MX (1) MX9803841A (es)
PT (1) PT874992E (es)
WO (1) WO1997018475A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
US6228372B1 (en) * 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6419933B1 (en) 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
WO1999005528A1 (en) * 1997-07-28 1999-02-04 Immunetics Assay and device for identifying trypanosoma cruzi infection
US6908898B1 (en) * 1998-06-15 2005-06-21 Lars Holmgren Angiogenesis related molecules
EP0976763B1 (en) * 1998-07-30 2003-11-05 Innogenetics N.V. Antigens and immunoassays for diagnosing Chagas' disease
FR2788527A1 (fr) 1999-01-15 2000-07-21 Bio Merieux Pseudopeptide, procede de synthese, reactif et applications
PE20050942A1 (es) * 2003-12-04 2005-11-10 Louis V Kirchhoff Polipeptidos recombinantes para diagnosticar la infeccion con el trypanosoma cruzi
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
BRPI0915371A2 (pt) * 2008-07-04 2016-10-18 Inst Rech Developpement Ird um método para avaliação de proteínas secretadas conservadas
FR2945290A1 (fr) * 2009-05-07 2010-11-12 Maan Zrein Anticorps biomarqueur et dispositif de diagnostic pour la detection de certaines maladies auto-immunes
FR2958753B1 (fr) * 2010-04-13 2018-03-16 Institut De Recherche Pour Le Developpement (Ird) Construction antigenique et ses applications pour le depistage de trypanosomoses chez l'homme et l'animal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) * 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) * 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) * 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (es) * 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) * 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection

Also Published As

Publication number Publication date
DE69619405D1 (de) 2002-03-28
DK0874992T3 (da) 2002-03-25
EP0874992B1 (en) 2002-02-20
WO1997018475A1 (en) 1997-05-22
AR004567A1 (es) 1998-12-16
ES2168520T3 (es) 2002-06-16
BRPI9611455B1 (pt) 2008-11-04
PT874992E (pt) 2002-08-30
BRPI9611455B8 (pt) 2014-07-01
ATE213544T1 (de) 2002-03-15
AU722152B2 (en) 2000-07-20
DE69619405T2 (de) 2002-10-17
CA2237299A1 (en) 1997-05-22
EP0874992A1 (en) 1998-11-04
AU1056897A (en) 1997-06-05
JP2000503111A (ja) 2000-03-14
US5916572A (en) 1999-06-29
BR9611455A (pt) 2001-01-02

Similar Documents

Publication Publication Date Title
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
GR3026096T3 (en) Erythropoietin(EPO)-peptides and antibodies against them
MX9803841A (es) Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.
NO975598D0 (no) Monoklonale ape-antistoffer som er spesifikke for primatiserte humane B7.1- og/eller B7.2-former, samt farmasöytiske sammensetninger
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
AU3245000A (en) Compounds and methods for the detection and prevention of (t. cruzi) infection
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
FR2651108B1 (fr) Appareil pour la preparation de boissons chaudes a dispositif d'obturation.
CA2078549A1 (en) Multiple sclerosis t-cell receptor
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
DK0882132T3 (da) Et kombineret humant cytomegalovirus-antigen og anvendelse heraf
BR9813637A (pt) Compostos e métodos para a detecção e prevençãode infecção por t. cruzi
CA2178635A1 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
AU659873B2 (en) Human monoclonal antibody against glycoprotein IIb/IIIa
EP0320866A3 (en) A protective immunodominant epitope included in the s1 subunit of pertussis toxin
FR2653096B1 (fr) Dispositif de protection d'empilement de tuyaux.
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
IT1242293B (it) Dispositivo per l'imballaggio di flaconi.
ITMI912195A0 (it) Dispositivo di chiusura per termos caraffe e simili
GB2267148B (en) Footrot antigens,vaccines and diagnostic assays
ZA98587B (en) A novel antigen from P. aeruginosa, and its use in medicine.
IT8622329A0 (it) Dispositivo ad arpionismo per lachiusura di prote di furgoni, contenitori e simili.
FI950253A (fi) Fimbria-antigeenejä, -vasta-aineita, -osoitusmenetelmiä ja -rokotteita
FR2684964B1 (fr) Dispositif d'obturation de contenants.
IT1281063B1 (it) Dispositivo di chiusura con sicurezza per borse e simili.